These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21795600)

  • 1. TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.
    Borbulevych OY; Santhanagopolan SM; Hossain M; Baker BM
    J Immunol; 2011 Sep; 187(5):2453-63. PubMed ID: 21795600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR-induced alteration of primary MHC peptide anchor residue.
    Madura F; Rizkallah PJ; Legut M; Holland CJ; Fuller A; Bulek A; Schauenburg AJ; Trimby A; Hopkins JR; Wells SA; Godkin A; Miles JJ; Sami M; Li Y; Liddy N; Jakobsen BK; Loveridge EJ; Cole DK; Sewell AK
    Eur J Immunol; 2019 Jul; 49(7):1052-1066. PubMed ID: 31091334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific roles of each TCR hemichain in generating functional chain-centric TCR.
    Nakatsugawa M; Yamashita Y; Ochi T; Tanaka S; Chamoto K; Guo T; Butler MO; Hirano N
    J Immunol; 2015 Apr; 194(7):3487-500. PubMed ID: 25710913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational design of the affinity and specificity of a therapeutic T cell receptor.
    Pierce BG; Hellman LM; Hossain M; Singh NK; Vander Kooi CW; Weng Z; Baker BM
    PLoS Comput Biol; 2014 Feb; 10(2):e1003478. PubMed ID: 24550723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.
    Borbulevych OY; Insaidoo FK; Baxter TK; Powell DJ; Johnson LA; Restifo NP; Baker BM
    J Mol Biol; 2007 Oct; 372(5):1123-36. PubMed ID: 17719062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides.
    Madura F; Rizkallah PJ; Holland CJ; Fuller A; Bulek A; Godkin AJ; Schauenburg AJ; Cole DK; Sewell AK
    Eur J Immunol; 2015 Feb; 45(2):584-91. PubMed ID: 25471691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
    Baumgaertner P; Schmidt J; Costa-Nunes CM; Bordry N; Guillaume P; Luescher I; Speiser DE; Rufer N; Hebeisen M
    Front Immunol; 2022; 13():973986. PubMed ID: 36032094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific increase in potency via structure-based design of a TCR.
    Malecek K; Grigoryan A; Zhong S; Gu WJ; Johnson LA; Rosenberg SA; Cardozo T; Krogsgaard M
    J Immunol; 2014 Sep; 193(5):2587-99. PubMed ID: 25070852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biological Evaluation of Hapten-Clicked Analogues of The Antigenic Peptide Melan-A/MART-1
    Tarbe M; Miles JJ; Edwards ESJ; Miles KM; Sewell AK; Baker BM; Quideau S
    ChemMedChem; 2020 May; 15(9):799-807. PubMed ID: 32162475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
    Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
    Front Immunol; 2019; 10():2076. PubMed ID: 31552033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and molecular recognition of melanoma-associated antigen-specific human γδ T cells.
    Benveniste PM; Roy S; Nakatsugawa M; Chen ELY; Nguyen L; Millar DG; Ohashi PS; Hirano N; Adams EJ; Zúñiga-Pflücker JC
    Sci Immunol; 2018 Dec; 3(30):. PubMed ID: 30552102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.
    Ekeruche-Makinde J; Clement M; Cole DK; Edwards ES; Ladell K; Miles JJ; Matthews KK; Fuller A; Lloyd KA; Madura F; Dolton GM; Pentier J; Lissina A; Gostick E; Baxter TK; Baker BM; Rizkallah PJ; Price DA; Wooldridge L; Sewell AK
    J Biol Chem; 2012 Oct; 287(44):37269-81. PubMed ID: 22952231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.
    Johnson LA; Heemskerk B; Powell DJ; Cohen CJ; Morgan RA; Dudley ME; Robbins PF; Rosenberg SA
    J Immunol; 2006 Nov; 177(9):6548-59. PubMed ID: 17056587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.
    Jäger E; Höhn H; Necker A; Förster R; Karbach J; Freitag K; Neukirch C; Castelli C; Salter RD; Knuth A; Maeurer MJ
    Int J Cancer; 2002 Mar; 98(3):376-88. PubMed ID: 11920589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue.
    Maeurer MJ; Necker A; Salter RD; Castelli C; Höhn H; Karbach J; Freitag K; Neukirch C; Knuth A; Jäger E
    Int J Cancer; 2002 Jan; 97(1):64-71. PubMed ID: 11774245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition.
    Dutoit V; Guillaume P; Romero P; Cerottini JC; Valmori D
    Cancer Immun; 2002 Jul; 2():7. PubMed ID: 12747752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of orthologous melan-A peptide immunizations on the anti-self melan-A/HLA-A2 T cell cross-reactivity.
    Colombetti S; Fagerberg T; Baumgärtner P; Chapatte L; Speiser DE; Rufer N; Michielin O; Lévy F
    J Immunol; 2006 Jun; 176(11):6560-7. PubMed ID: 16709813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.